Proteasome Inhibition With Bortezomib Induces a Therapeutically Relevant Depletion of Plasma Cells in SLE but Does Not Target Their Precursors
European Journal of Immunology - United Kingdom
doi 10.1002/eji.201847492
Full Text
Open PDFAbstract
Available in full text
Date
July 30, 2018
Authors
Publisher
Wiley